W.E. van Spil

3.3k citations
41 papers · 1.5k · h-index 20

Impact in

  • Rheumatology top 0.5%
    • Osteoarthritis Treatment and Mechanisms
    • Rheumatoid Arthritis Research and Therapies
  • Pharmacology top 2%
    • Inflammatory mediators and NSAID effects

Papers in

  • Rheumatology 37
    • Osteoarthritis Treatment and Mechanisms 33
    • Rheumatoid Arthritis Research and Therapies 12
  • Pharmacology 15
    • Inflammatory mediators and NSAID effects 15
Co-authors
F.P.J.G. Lafeber (11 shared papers)Ali Mobasheri (7 shared papers)Anne‐Christine Bay‐Jensen (8 shared papers)J. W. J. Bijlsma (4 shared papers)S.C. Mastbergen (5 shared papers)Jeroen DeGroot (2 shared papers)Jonathan Larkin (4 shared papers)Marc C. Levesque (3 shared papers)
Journals
Osteoarthritis and Cartilage (24 papers)BMJ Open (2 papers)Annals of the Rheumatic Diseases (2 papers)PLoS ONE (2 papers)Scientific Reports (1 paper)
Partner nations
NetherlandsUnited KingdomDenmark

In The Last Decade

W.E. van Spil

41 papers receiving 1.5k citations

Peers

W.E. van Spil
Comparison fields: 5 of 96
  • Rheumatology 1.2k
  • Pharmacology 421
  • Equine 37
  • Orthopedics and Sports Medicine 148
  • Immunology and Allergy 57
Replace Alexander Mathiessen with:
Alexander Mathiessen Norway
Ruth Wittoek Belgium
J.R. Andersen Denmark
F. Galdo Spain
Christian S. Thudium Denmark
Florent Eymard France
Thomas Funck‐Brentano France
Francis X. Burch United States
J-P Pelletier Canada
S. Larsson Sweden
W.E. van Spil relative to Alexander Mathiessen Norway Alexander Mathiessen's profile →
Citations per field
00.5×2×3.1×
Alexander Mathiessen · 1×
Citations per year

Countries citing papers authored by W.E. van Spil

Since Specialization
Citations

This map shows the geographic impact of W.E. van Spil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W.E. van Spil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W.E. van Spil more than expected).

Fields of papers citing papers by W.E. van Spil

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W.E. van Spil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W.E. van Spil. The network helps show where W.E. van Spil may publish in the future.

Co-authors

The 25 scholars most cited alongside W.E. van Spil, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with W.E. van Spil Line = papers co-authored together W.E. van Spil links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Serum adipokines in osteoarthritis; comparison with controls and relationship with local parameters of synovial inflammation and cartilage damage
Osteoarthritis and Cartilage ·T.N. de Boer, W.E. van Spil, A.M. Huisman, A.A. Polak, J. W. J. Bijlsma, F.P.J.G. Lafeber, S.C. Mastbergen
2012225
2
Osteoarthritis phenotypes and novel therapeutic targets
Biochemical Pharmacology ·W.E. van Spil, Olga Kubassova, Mikael Boesen, Anne‐Christine Bay‐Jensen, Ali Mobasheri
2019161
3
Serum and urinary biochemical markers for knee and hip-osteoarthritis: a systematic review applying the consensus BIPED criteria
Osteoarthritis and Cartilage ·W.E. van Spil, Jeroen DeGroot, Willem F. Lems, Johanna C. M. Oostveen, F.P. Lafeber
2010146
4
Osteoarthritis Year in Review 2016: biomarkers (biochemical markers)
Osteoarthritis and Cartilage ·Ali Mobasheri, Anne‐Christine Bay‐Jensen, W.E. van Spil, Jonathan Larkin, Marc C. Levesque
2017123
5
An explorative study comparing levels of soluble mediators in control and osteoarthritic synovial fluid
Osteoarthritis and Cartilage ·M. Beekhuizen, Lobke Gierman, W.E. van Spil, Gerjo J. V. M. van Osch, T. Huizinga, Daniël B.F. Saris, Laura B. Creemers, A.‐M. Zuurmond
2013109
6
Molecular taxonomy of osteoarthritis for patient stratification, disease management and drug development: biochemical markers associated with emerging clinical phenotypes and molecular endotypes
Current Opinion in Rheumatology ·Ali Mobasheri, W.E. van Spil, Emma Budd, Ilona Uzielienè, Eiva Bernotienė, Anne‐Christine Bay‐Jensen, Jonathan Larkin, Marc C. Levesque, Oreste Gualillo, Yves Henrotin
201887
7
Associations of CTX-II with biochemical markers of bone turnover raise questions on its tissue origin: data from CHECK, a cohort study of early osteoarthritis
Annals of the Rheumatic Diseases ·W.E. van Spil, K.W. Drossaers-Bakker, Floris P. J. G. Lafeber
201260
8
Osteoarthritis year 2013 in review: biomarkers; reflecting before moving forward, one step at a time
Osteoarthritis and Cartilage ·F.P.J.G. Lafeber, W.E. van Spil
201358
9
Cross-sectional and predictive associations between plasma adipokines and radiographic signs of early-stage knee osteoarthritis: data from CHECK
Osteoarthritis and Cartilage ·W.E. van Spil, P.M. Welsing, M. Kloppenburg, Sita Bierma‐Zeinstra, J. W. J. Bijlsma, S.C. Mastbergen, F.P.J.G. Lafeber
201255
10
Clusters within a wide spectrum of biochemical markers for osteoarthritis: data from CHECK, a large cohort of individuals with very early symptomatic osteoarthritis
Osteoarthritis and Cartilage ·W.E. van Spil, N.W. Jansen, J. W. J. Bijlsma, Max Reijman, Jeroen DeGroot, Paco M J Welsing, F.P.J.G. Lafeber
201254
11
Cohort profile: The Applied Public-Private Research enabling OsteoArthritis Clinical Headway (IMI-APPROACH) study: a 2-year, European, cohort study to describe, validate and predict phenotypes of osteoarthritis using clinical, imaging and biochemical markers
BMJ Open ·E.M. van Helvoort, W.E. van Spil, Mylène P. Jansen, Paco M J Welsing, M. Kloppenburg, M. Loef, Francisco J. Blanco, I.K. Haugen, Francis Bérenbaum, Jaume Bacardit, C. Ladel, John Loughlin, Anne‐Christine Bay‐Jensen, Ali Mobasheri, Jonathan Larkin, Janneke Boere, Harrie Weinans, Alain Lalande, A.C. Marijnissen, Floris P. J. G. Lafeber
202053
12
Osteoarthritis year in review 2019: biomarkers (biochemical markers)
Osteoarthritis and Cartilage ·W.E. van Spil, I Szilágyi
201951
13
The ability of systemic biochemical markers to reflect presence, incidence, and progression of early-stage radiographic knee and hip osteoarthritis: data from CHECK
Osteoarthritis and Cartilage ·W.E. van Spil, Paco M J Welsing, Sita Bierma‐Zeinstra, J. W. J. Bijlsma, Leo D. Roorda, H. Cats, F.P.J.G. Lafeber
201537
14
Bone texture analysis for prediction of incident radiographic hip osteoarthritis using machine learning: data from the Cohort Hip and Cohort Knee (CHECK) study
Osteoarthritis and Cartilage ·Jukka Hirvasniemi, Willem Paul Gielis, Saeed Arbabı, Rintje Agricola, W.E. van Spil, Vahid Arbabi, Harrie Weinans
201936
15
Systemic biochemical markers of joint metabolism and inflammation in relation to radiographic parameters and pain of the knee: data from CHECK, a cohort of early-osteoarthritis subjects
Osteoarthritis and Cartilage ·W.E. van Spil, Sandhya Nair, M.B. Kinds, Pieter J. Emans, W.K. Hilberdink, Paco M J Welsing, F.P.J.G. Lafeber
201433
16
The clinical and radiographic course of early knee and hip osteoarthritis over 10 years in CHECK (Cohort Hip and Cohort Knee)
Osteoarthritis and Cartilage ·D. Schiphof, J. Runhaar, J.H. Waarsing, W.E. van Spil, Marienke van Middelkoop, Sita Bierma‐Zeinstra
201932
17
Lack of evidence of a beneficial effect of azathioprine in dogs treated with prednisolone for idiopathic immune-mediated hemolytic anemia: a retrospective cohort study
BMC Veterinary Research ·Christine J. Piek, W.E. van Spil, Greet Junius, A. Dekker
201132
18
Bone phenotypes in rheumatology – there is more to bone than just bone
BMC Musculoskeletal Disorders ·Christian S. Thudium, Signe Holm Nielsen, Samra Sardar, Ali Mobasheri, W.E. van Spil, Rik Lories, Kim Henriksen, Anne‐Christine Bay‐Jensen, M.A. Karsdal
202021
19
Six weeks of continuous joint distraction appears sufficient for clinical benefit and cartilaginous tissue repair in the treatment of knee osteoarthritis
The Knee ·J. A. D. van der Woude, Ronald J. van Heerwaarden, S. Spruijt, F. Eckstein, S. Maschek, P.M. van Roermund, Roel J.H. Custers, W.E. van Spil, S.C. Mastbergen, F.P.J.G. Lafeber
201621
20
Alterations in the chondrocyte surfaceome in response to pro-inflammatory cytokines
BMC Molecular and Cell Biology ·Bernadette Jeremiasse, Csaba Matta, Christopher R. Fellows, David J. Boocock, Julia R. Smith, Susan Liddell, Floris P. J. G. Lafeber, W.E. van Spil, Ali Mobasheri
202019

About W.E. van Spil

W.E. van Spil is a scholar working on Rheumatology, Pharmacology, Surgery, Biomedical Engineering and Oncology, having authored 41 papers that have together received 1.5k indexed citations. Recurring topics across this work include Osteoarthritis Treatment and Mechanisms (33 papers), Inflammatory mediators and NSAID effects (15 papers), Rheumatoid Arthritis Research and Therapies (12 papers), Total Knee Arthroplasty Outcomes (9 papers), Lower Extremity Biomechanics and Pathologies (7 papers), Knee injuries and reconstruction techniques (5 papers), Hip disorders and treatments (4 papers) and Bone and Joint Diseases (4 papers). The work is most often cited by research in Rheumatology (1.2k citations), Pharmacology (421 citations), Equine (37 citations), Orthopedics and Sports Medicine (148 citations) and Immunology and Allergy (57 citations). W.E. van Spil has collaborated with scholars based in Netherlands, United Kingdom and Denmark. Frequent co-authors include F.P.J.G. Lafeber, Ali Mobasheri, Anne‐Christine Bay‐Jensen, J. W. J. Bijlsma, S.C. Mastbergen, Jeroen DeGroot, Jonathan Larkin, Marc C. Levesque, A.M. Huisman and Mikael Boesen. Their work appears in journals such as Osteoarthritis and Cartilage, BMJ Open, Annals of the Rheumatic Diseases, PLoS ONE and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alexander MathiessenBreakdown of academic impact, for papers by Ruth WittoekBreakdown of academic impact, for papers by J.R. AndersenBreakdown of academic impact, for papers by F. GaldoBreakdown of academic impact, for papers by Christian S. ThudiumBreakdown of academic impact, for papers by Florent EymardBreakdown of academic impact, for papers by Thomas Funck‐BrentanoBreakdown of academic impact, for papers by Francis X. BurchBreakdown of academic impact, for papers by J-P PelletierBreakdown of academic impact, for papers by S. Larsson